HIM
SONM icon

Herald Investment Management’s DNA X Inc SONM Stock Holding History

Herald Investment Management’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-628
Closed -$876K – 97
2020
Q3 		$876K Hold
628
– – 0.19% 85
2020
Q2 		$905K Buy
+628
New +$1M 0.21% 79

Other funds holding SONM

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
USPCM
Union Square Park Capital Management New York $176M AUM 51.52% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Herald Investment Management's SONM Position: Q4 2020 in Review

Herald Investment Management sold out of DNA X Inc (SONM) in Q4 2020, closing a stake of 628 shares — an estimated $876K sold.

Herald Investment Management first reported a position in SONM in Q2 2020 and held it in 2 quarters. The position peaked at $905K in Q2 2020. 28 funds tracked by Wall St. Rank hold SONM as of Q4 2020.

  • Herald Investment Management reported no remaining DNA X Inc position as of Q4 2020 after selling out during the quarter.
  • Herald Investment Management sold 628 DNA X Inc shares in Q4 2020, an estimated $876K.
  • Herald Investment Management first reported a position in DNA X Inc in Q2 2020 and held it in 2 quarters.
  • Herald Investment Management's DNA X Inc position peaked at $905K in Q2 2020.
  • 28 funds tracked by Wall St. Rank held DNA X Inc as of Q4 2020.

Based on Herald Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.